Instead of regulating MAPK pathways, we found that there is an interaction between MAP4K4 and ACSL4 that mediates radioresistance in breast cancer cells, with MAP4K4 acting as an upstream activator of ACSL4. Here, ACSL4 is linked to breast carcinoma.